Prenetics Global Ltd
- Last sale
- Nov 12, 2026 · -5.62%
- Market cap
- $281.97M
- 16.87M shares
- Filings
- 273
FY 2024+40.8% FY24 yoy
FY 2024N/M FY24 yoy
FY 2024N/M FY24 yoy
FY 2024derivedN/M FY24 yoy
FY 2024N/M FY24 yoy
FY 2024+14.3% FY24 yoy
- $281.97M
- —
- —
- —
- —
- —
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $30,621,000 | reported | |
| FY 2023 | 2023-12-31 | $21,742,675 | reported | |
| FY 2022 | 2022-12-31 | $13,163,841 revised | reported | |
| FY 2021 | 2021-12-31 | $12,532,744 revised | reported | |
| FY 2020 | 2020-12-31 | $65,179,515 | reported |
Segments
LineFY2022ShareChange
Diagnostics$259.99M1975%+0.3%
Prevention$15.77M120%−4.8%
Total$13.16M
Pharmaceutical preparations
Prenetics Global Ltd is the 227th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
NIKANika Pharmaceuticals, Inc———$291.2MVOGXVogenx, Inc.———$283.9MFULCFulcrum Therapeutics, Inc.$0.0100.0%—$282.6MLRMRLarimar Therapeutics, Inc.———$282.0M
PREPrenetics Global Ltd (this company)———$282.0M
PRLDPrelude Therapeutics Inc$12.1M73.4%819.6%$281.8MINOInovio Pharmaceuticals, Inc.$65.3K70.0%130,000.0%$274.4MFTHFaeth Therapeutics, Inc.———$272.4MRCKTRocket Pharmaceuticals, Inc.$0.0——$268.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Prenetics Global Ltd · CIK 1876431 · Engraved from SEC EDGAR